Generic medicines policies in the Asia Pacific region: ways forward
AbstractGeneric medicines are a key strategy used by governments and third‑party payers to contain medicines costs and improve the access to essential medicines. This strategy represents an important opportunity provided by the global intellectual property regimes to discover and develop copies of original products marketed by innovator companies once the patent protection term is over. While there is an extensive experience regarding generic medicines policies in developed countries, this evidence may not translate to developing countries. The generic medicines policies workshop at the Asia Pacific Conference on National Medicines Policies 2012 provided an important opportunity to discuss and document country‑specific initiatives for improving access to and the rational of use of generic medicines in the Asia Pacific region. Based on the identified barriers and enablers to implementation of generic medicines policies in the region, a set of future action plans and recommendations has been made.
Tuan A. Nguyen, Mohamed A. A. Hassali & Andrew McLachlan. (2013). Generic medicines policies in the Asia Pacific region: ways forward. WHO South-East Asia Journal of Public Health, 2 (1), 72 - 74. World Health Organization. Regional Office for South-East Asia. https://apps.who.int/iris/handle/10665/329775
JournalWHO South-East Asia Journal of Public Health, 2 (1): 72 - 74